Ovintiv Other Non-Current Liabilities increased by 124.0% to $224.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 71.0%, from $131.00M to $224.00M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -22.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $206.00M | $215.00M | $190.00M | $170.00M | $154.00M | $153.00M | $131.00M | $116.00M | $118.00M | $124.00M | $132.00M | $128.00M | $141.00M | $156.00M | $114.00M | $131.00M | $130.00M | $132.00M | $100.00M | $224.00M |
| QoQ Change | — | +4.4% | -11.6% | -10.5% | -9.4% | -0.6% | -14.4% | -11.5% | +1.7% | +5.1% | +6.5% | -3.0% | +10.2% | +10.6% | -26.9% | +14.9% | -0.8% | +1.5% | -24.2% | +124.0% |
| YoY Change | — | — | — | — | -25.2% | -28.8% | -31.1% | -31.8% | -23.4% | -19.0% | +0.8% | +10.3% | +19.5% | +25.8% | -13.6% | +2.3% | -7.8% | -15.4% | -12.3% | +71.0% |